Drug resistant breast cancer may have met its match in a drug called metformin. Dr. Terra Arnason and her team at the University of Saskatchewan took on a five-year-long study research the effects of metformin on multiple drug resistant breast cancer. Dr. Terra Arnason is a clinician scientist and adult endocrinologist associate professor at the University of Saskatchewan. The findings suggesting metformin can keep breast cancer cells from developing drug resistance, and can reverse drug resistance after it has appeared. The team focused on drug-resistant breast cancer because women often successfully fight off the disease only for it to reappear later in life.

Source: CBC News January 07, 2018 15:00 UTC